Veterinary Vaccines Market Booms, Expected to Reach USD 19.06 Billion by 2032

The Veterinary Vaccines Market was valued at USD 12.12 billion in 2024, projected to reach USD 19.06 billion by 2032, with a CAGR of 5.84%. The United States Veterinary Vaccines Market is expected to grow to USD 6.22 billion by 2032, driven by a robust livestock sector and increasing pet adoption rates.

The global veterinary vaccines industry is growing rapidly to curb infectious animal diseases, with a focus on mass vaccination programs to reduce economic losses in livestock farming and prevent disease outbreaks.

Livestock vaccines generated the most revenue in 2024, but companion animal vaccines are on the rise. Thermostable vaccines and DNA-based formulations are shaping a more resilient global veterinary vaccine supply chain.

North America led the market in 2024, while the Asia Pacific region is the fastest-growing, with countries like China and India investing in vaccine manufacturing and public health.

Recent developments include Qatar and Belarus cooperating on local veterinary vaccines and over 500 dogs being vaccinated in Andhra Pradesh during World Zoonosis Day.

For more information on the Veterinary Vaccines Market, visit the SNS Insider website for a detailed report and analysis.

Read more at GlobeNewswire: Veterinary Vaccines Market to Surpass USD 19.06 Billion by